FOcus on Reducing Dose-limiting Toxicities in Colon Cancer With Resistance Exercise Study

NACompletedINTERVENTIONAL
Enrollment

183

Participants

Timeline

Start Date

February 23, 2018

Primary Completion Date

March 21, 2022

Study Completion Date

March 21, 2022

Conditions
Resistance TrainingColon CancerChemotherapy Effect
Interventions
BEHAVIORAL

Resistance training

The intervention goal is for study participants to exercise with progressively higher weights for resistance training to achieve a 1-kg increase in lean body mass by the end of the intervention. During an in-person visit on the same day as a chemotherapy infusion session, exercise professionals will teach participants a series of exercises to be completed at home twice weekly throughout the intervention. Participants will also receive protein powder, which they will be instructed to consume with meals twice a day. During subsequent infusion sessions, the exercise professional will meet in-person with participants to evaluate their ability to increase weights, and adjust exercises appropriately. In between visits, the exercise professional will check-in with participants by phone.

Trial Locations (3)

17033

Penn State Cancer Institute, Hershey

94612

Kaiser Permanente Division of Research, Oakland

02215

Dana Farber Cancer Institute, Boston

All Listed Sponsors
collaborator

Dana-Farber Cancer Institute

OTHER

collaborator

Penn State University

OTHER

lead

Kaiser Permanente

OTHER

NCT03291951 - FOcus on Reducing Dose-limiting Toxicities in Colon Cancer With Resistance Exercise Study | Biotech Hunter | Biotech Hunter